More than half of the states in our country have introduced and implemented laws authorizing the use of marijuana for medical use. A ‘growing’ handful of states have also authorized the personal (‘recreational’) use of marijuana. These state laws are in direct conflict with the federal Controlled Substances Act(CSA)(21 USC §812), which still holds that the possession of marijuana is a crime.
These relatively new state laws have been mostlyuninterpreted by either state or federal courts, but the few cases that have been decidedin recent years have been, for the most part, state-levelcourt decisions. Interestingly, a recent federal district court case has added some nuanced elements to the critical question of how these marijuana laws can coexist with the CSA that still classifies marijuana as a ‘drug with no currently accepted medical use and a high potential for abuse.’
Terminating an employee who tested positive for marijuana was once a reasonably risk-free decision. Not so much these days. We want to emphasize an aspect of these cases that we believe indicate where medical marijuana (and the prescription drug abuse crisis) are driving this corner of employment law – state disability discrimination laws.
One of the most publicized cases comes from Connecticut, Noffsinger v. SSC Niantic Operating Company LLC, d/b/a Bride Brook Nursing & Rehabilitation Center (2018)
Last year the Federal District Court in Connecticut ruled that the federal Controlled Substances Act did not preempt Connecticut’s Palliative Use of Marijuana Act(PUMA). This was the first and to date the onlyfederalcourt to do so. Now that same Court hadruled that the employer violated the anti-discrimination provisions of PUMA when it withdrew its offer of employment due to the applicant’s statusas a medical marijuana patient.
The facts of the case are undisputed. Katelin Noffsinger was recruitedfor the position of Activities Manager at Bride Brook Facility, run by Defendant SSC Niantic Operating Company, LLC. (The Company). She was offeredand accepted that position, contingent upon the completion of pre-employment screening, including a drug test. She disclosed to the Facility Administrator that she used marijuana at home at night for PTSD symptoms stemming from a car accident. She took the required pre-employmentdrug test and was reported positive for marijuana (THC). After some internal discussions,Noffsingerwas informedthat her job offer was being rescindeddue to her positive pre-employmentdrug test.
Noffsingersued alleging, among other things, that the Company violated PUMA’s anti-discrimination provisions. PUMA’s anti-discrimination provision provides in relevant part:
“[U]nless required by federal law or required to obtain funding: . . . (3) No employer may refuse to hire a person or may discharge, penalize or threaten an employee solely on the basis of such person’s or employee’s statusas a qualifying patient or primary caregiver under[the law]. Nothing in this subdivision shall restrict an employer’s ability to prohibit the use of intoxicating substances during work hours or restrict an employer’s ability to discipline an employee for being under the influence of intoxicating substances during work hours.”[emphasis added]
The Company presented five arguments related to the anti-discrimination issue raised by Noffsinger, all of which the Court found “meritless.”Notable for this discussion, the Company argued that it is exempt from PUMA’s anti-discrimination provision because, as a federal contractor, the federal Drug-FreeWorkplace Act  (DFWA) “allows for an exception if the discrimination is required by federal law or required to obtain federal funding.” The Court disagreed pointing out that the DFWA does not require drug testing nor does it prohibit the Company from employing someone who uses illegal drugs outside the workplace. The Court said that the Company’s choice of a zero-tolerance policy was “not required by federal law or required to obtain federal funding.”
The Company also argued that the law prohibits discrimination based on a person’s status as a medical marijuana patient but not on their useof marijuana. The Court found that this suggestion “makes no sense.” PUMA protects a user from employment discriminationpursuant totheir status as a qualified medical marijuana patient. Additionally, the language of PUMA makes clear that qualifiedmedical marijuana users are protected from discrimination at work for using marijuana outside working hours.
Noffsinger comes on the heels of two other medical marijuana cases, both on a state level.
In New York, the Compassionate Care Act was implemented in January 2016 permitting medical marijuana use for specific medical conditions. Pursuant tothe Act, “Certified Patients” prescribed medical marijuana are deemed to have a disability under the New York State Human Rights Law (NYSHRL). Thismeans that New York employers with four or more employees are prohibitedfrom terminating or refusing to employ an individual on the basis ofhis/her status as a certified medical marijuana patient. Further, employers must reasonably accommodate an employee who is a “Certified Patient” as a result of his/her deemed disability. The Act specifically provides that Certified Patients shall not be subject to “disciplinary action by a business . . . solelyfor the certified medical use or manufacture of” marijuana. Accordingly, an employer may be subject to a discrimination claim if it fires or disciplines an employee for lawfully consuming or manufacturing marijuana under the Act.
In Rhode Island, Callaghan v. Darlington Fabrics Corporation, et al.(2017) a case in the state trialcourt held that the employer violated the state’s medical marijuana statute prohibiting discrimination based on the employee’s statusas a medical marijuana patient.
In Massachusetts, Barbuto v. Advantage Sales and Marketing, LLC (2017) the state Supreme Judicial Court agreed with an employee’s argument that her employer discriminated against her based on her handicap, manifested by the recommendation to treat it with medical marijuana. The state’s medical marijuana law was secondary to the decision; the case was broughtunder the state’s human rights law. The court, in this case, treated marijuana as if it was any other form of medication recommended by a doctor.
Treating marijuana like any other medication, the Court concluded the employer would have a duty to “engage in an interactive process with the employee to determine whether there were equally effective medical alternatives to the prescribed medication whose use would not be in violation of its policy.”
Where no alternative medications exist, the Court said the employer would bear the burden of proving that the employee’s use of the medication would cause undue hardship to theemployer, that any reasonable accommodation to the drug testing policy could not be made, and the employee’s medical needs could not be reasonably accommodated.
The Court remanded the case to the Superior Courtfor further proceedings consistent with the Supreme Judicial Court’s findings and to allow the parties a chance to prove their arguments.
The answer to this question depends on where your company operates, what state and federal laws apply, the specific language contained in the state law(s), what court and agency decisions have been issued, and the details within your company’s policy and procedures. Cases like these will continue to plague employers across the nation, the time to act is now.
Employers must begin to recognize that STATE disability discrimination laws exist and will limit employment actions when it comes to the medical use of marijuana and when testing for prescription medications.
It is essentialto train your human resources professionals, managers, and supervisors regarding employees’ rights and employers’ obligations under state and federal discrimination laws.
Employers must evolve. Procedures must be implemented to ensure that, when appropriate, an “interactive dialogue” takes place with employees in an attempt to accommodate a disabled employee. Employers should review, and if necessary, revise, handbooks, policies, andprocedures pertaining to the issues of employee marijuana and prescription drug use.
Marijuana in the workplace and prescription drug use is, unfortunately, an ever-changing, complicated landscape of regulations. While the complexity may be frustrating and a bit daunting, the cost of non-compliance (potentially reaching into the millions of dollars) all but forces you to be proactive and knowledgeable about the issue. Thepart of the marijuana question (whether federal regulations take precedence over state protections) will dramatically alter an employer’s requirements in individualstates because it will answer the question, “Which rules do I need to follow?”. Every state is different. We strongly recommend that you take steps to monitor this topic and regularly stay tuned for updates that will inevitably come with the potential to impact how you conduct your business.
21 U.S.C. §801 et seq. (CSA).
Noffsinger v. SSC Niantic Operating Co. LLC, 273 F. Supp. 3d 326 (D. Conn. 2017). PUMA at Conn. Gen. Stat. §21a-408et seq.
Noffsinger v. SSC Niantic Operating Co. LLC, No. 3:16-cv-01938 (JAM) (D. Conn. Sept 5, 2018), Order on Cross Motions for Summary Judgment. Copy available upon request.
Conn. Gen. Stat. §21a-408p(b)(3). Copies of the statute available upon request.
The Court ruled in the Company’s favor denying Noffsinger’srequest for punitive damages and attorney’s fees, and on Noffsinger’s claim for negligent infliction of emotional distress.
41 U.S.C. §8102.
Noffsinger, at page 6.
Noffsinger, at page 6.